An Active Surveillance Study to Monitor the Safety of Abrocitinib Among Real-World Patients with Atopic Dermatitis (AD) in the European Union (EU) (B7451084)

First published 30/10/2024

Last updated 11/11/2025

EU PAS number:

EUPAS1000000282

Study

Ongoing

Documents

Study protocol

Updated protocol

B7451084_ABROCITINIB PROTOCOL AMENDMENT 1_23MAY2024.pdf

First published: 24/07/2024

English (1.6 MB - PDF) View document

Study results

Study report

B7451084_PROGESS REPORT 1_06OCT2025.pdf

English (274.72 KB - PDF) View document

Other information

Secondary tabs